Athosmedtech

1 known investors

Athos Medical Technology develops inhalation drug delivery technology that increases the efficiency of inhaled medications reaching the lungs, with studies showing 94% of the inhaled dose entering systemic circulation compared to the current 33% standard. The technology targets improvement in treatment efficacy and reduced adverse effects for patients requiring inhaled medications.